Can you provide the average price target for UNIQURE NV stock?
22 analysts have analysed QURE and the average price target is 51.51 USD. This implies a price increase of 216.59% is expected in the next year compared to the current price of 16.27.
NASDAQ:QURE • NL0010696654
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNIQURE NV (QURE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-11 | Mizuho | Upgrade | Neutral -> Outperform |
| 2026-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-03-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-03-09 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2026-03-09 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-03-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-03-03 | Mizuho | Downgrade | Outperform -> Neutral |
| 2026-03-03 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-03-02 | Cantor Fitzgerald | Upgrade | Overweight -> Neutral |
| 2026-02-24 | Wolfe Research | Initiate | Peer Perform |
| 2026-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-28 | Barclays | Initiate | Equal-Weight |
| 2025-12-11 | Stifel | Maintains | Buy -> Buy |
| 2025-12-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-10 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-11-04 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-11-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.843M -85.12% | 27.119M 71.17% | 16.098M -40.64% | 36.401M 126.12% | 113.04M 210.54% | 143.22M 26.70% | 509.53M 255.77% | 858.69M 68.53% | 1.073B 24.96% | 814.9M -24.05% | 862.1M 5.79% | |
| EBITDA YoY % growth | -270.971M -101.17% | -164.463M 39.31% | -170.29M -3.54% | -153.075M 10.11% | -123.385M 19.40% | -132.232M -7.17% | 171.68M 229.83% | 542.73M 216.13% | 655.08M 20.70% | 767.64M 17.18% | N/A | |
| EBIT YoY % growth | -282.871M -97.54% | -177.104M 37.39% | -185.049M -4.49% | -202.81M -9.60% | -166.005M 18.15% | -250.673M -51.00% | 125.3M 149.99% | 401.3M 220.27% | 669.84M 66.92% | 562.4M -16.04% | 202M -64.08% | |
| Operating Margin | -1,785.46% | -653.06% | -1,149.52% | -557.16% | -146.86% | -175.03% | 24.59% | 46.73% | 62.43% | 69.01% | 23.43% | |
| EPS YoY % growth | -6.48 -138.72% | -4.95 23.62% | -3.53 28.69% | -3.46 2.09% | -2.18 36.93% | 0.68 131.06% | 2.20 224.63% | 6.02 173.83% | 9.47 57.38% | 6.88 -27.41% | 6.91 0.45% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 28 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.89 -8.49% | -0.97 -40.29% | -0.98 29.15% | -0.62 2.89% | -4.39 -393.12% | -0.89 |
| Revenue Q2Q % growth | 5.327M 239.95% | 6.574M 24.93% | 10.894M 194.35% | 7.293M 30.98% | 22.338M 319.34% | N/A |
| EBITDA Q2Q % growth | -45.118M -14.79% | -48.069M -41.34% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -51.081M -16.54% | -59.117M -40.20% | -61.506M -24.42% | -20.502M 58.68% | N/A | N/A |
All data in USD
22 analysts have analysed QURE and the average price target is 51.51 USD. This implies a price increase of 216.59% is expected in the next year compared to the current price of 16.27.
The consensus EPS estimate for the next earnings of UNIQURE NV (QURE) is -0.89 USD and the consensus revenue estimate is 5.33M USD.
The expected long term growth rate for UNIQURE NV (QURE) is 109.13%.